Nav: Home

Engineers grow functioning human muscle from skin cells

January 09, 2018

DURHAM, N.C. -- Biomedical engineers have grown the first functioning human skeletal muscle from induced pluripotent stem cells.

The advance builds on work published in 2015 when researchers at Duke University grew the first functioning human muscle tissue from cells obtained from muscle biopsies. The ability to start from cellular scratch using non-muscle tissue will allow scientists to grow far more muscle cells, provide an easier path to genome editing and cellular therapies, and develop individually tailored models of rare muscle diseases for drug discovery and basic biology studies.

The results appear online Tuesday, January 9, in Nature Communications.

"Starting with pluripotent stem cells that are not muscle cells, but can become all existing cells in our body, allows us to grow an unlimited number of myogenic progenitor cells," said Nenad Bursac, professor of biomedical engineering at Duke University. "These progenitor cells resemble adult muscle stem cells called 'satellite cells' that can theoretically grow an entire muscle starting from a single cell."

In their previous work, Bursac and his team started with small samples of human cells obtained from muscle biopsies, called "myoblasts," that had already progressed beyond the stem cell stage but hadn't yet become mature muscle fibers. They grew these myoblasts by many folds and then put them into a supportive 3-D scaffolding filled with a nourishing gel that allowed them to form aligned and functioning human muscle fibers.

In the new study, the researchers instead started with human induced pluripotent stem cells. These are cells taken from adult non-muscle tissues, such as skin or blood, and reprogrammed to revert to a primordial state. The pluripotent stem cells are then grown while being flooded with a molecule called Pax7 -- which signals the cells to start becoming muscle.

As the cells proliferated they became very similar to --but not quite as robust as -- adult muscle stem cells. While previous studies had accomplished this feat, nobody has been able to then grow these intermediate cells into functioning skeletal muscle.

The Duke researchers succeeded where previous attempts had failed.

"It's taken years of trial and error, making educated guesses and taking baby steps to finally produce functioning human muscle from pluripotent stem cells," said Lingjun Rao, a postdoctoral researcher in Bursac's laboratory and first author of the study. "What made the difference are our unique cell culture conditions and 3-D matrix, which allowed cells to grow and develop much faster and longer than the 2-D culture approaches that are more typically used."

Once the cells were well on their way to becoming muscle, Bursac and Rao stopped providing the Pax7 signaling molecule and started giving the cells the support and nourishment they needed to fully mature.

In the study, the researchers show that after two to four weeks of 3-D culture, the resulting muscle cells form muscle fibers that contract and react to external stimuli such as electrical pulses and biochemical signals mimicking neuronal inputs just like native muscle tissue. They also implanted the newly grown muscle fibers into adult mice and showed that they survive and function for at least three weeks while progressively integrating into the native tissue through vascularization.

The resulting muscle, however, is not as strong as native muscle tissue, and also falls short of the muscle grown in the previous study that started from muscle biopsies. Despite this caveat, the researchers say this muscle still holds potential that the stronger, older relative does not.

The pluripotent stem cell-derived muscle fibers develop reservoirs of "satellite-like cells" that are necessary for normal adult muscles to repair damage, while the muscle from the previous study had much fewer of these cells. The stem cell method is also capable of growing many more cells from a smaller starting batch than the biopsy method.

Both of the advantages point toward a possibility of using this new method for regenerative therapies and for creating models of rare diseases for future studies and individualized health care.

"The prospect of studying rare diseases is especially exciting for us," said Bursac. "When a child's muscles are already withering away from something like Duchenne muscular dystrophy, it would not be ethical to take muscle samples from them and do further damage. But with this technique, we can just take a small sample of non-muscle tissue, like skin or blood, revert the obtained cells to a pluripotent state, and eventually grow an endless amount of functioning muscle fibers to test."

The technique also holds promise for being combined with genetic therapies. Researchers could, in theory, fix genetic malfunctions in the induced pluripotent stem cells derived from a patient and then grow small patches of completely healthy muscle. While this could not heal or replace an entire body's worth of diseased muscle, it could be used in tandem with more widely targeted genetic therapies or to heal more localized problems.

The researchers are now refining their technique to grow more robust muscles and beginning work to develop new models of rare muscle diseases.
-end-
This work was supported by National Institutes of Health (UH3-TR000505, UG3-TR002142, AR065873, and AR070543).

CITATION: "Engineering Human Pluripotent Stem Cells Into a Functional Skeletal Muscle Tissue." Lingjun Rao, Ying Qian, Alastair Khodabukus, Thomas Ribar and Nenad Bursac. Nature Communications, January 2018. DOI: 10.1038/s41467-017-02636-4

Duke University

Related Pluripotent Stem Cells Articles:

A new method for creating safer induced pluripotent stem cells
Induced pluripotent stem cells (IPSCs) hold great promise in regenerative medicine, personalized medicine and drug discovery.
Approaching a decades-old goal: Making blood stem cells from patients' own cells
Researchers at Boston Children's Hospital have, for the first time, generated blood-forming stem cells in the lab using pluripotent stem cells, which can make virtually every cell type in the body.
Boston University scientists turn human induced pluripotent stem cells into lung cells
Boston University scientists have announced two major findings that further our understanding of how stem cells become organs: the ability to grow and purify the earliest lung progenitors that emerge from human stem cells, and the ability to differentiate these cells into tiny 'bronchospheres' that model cystic fibrosis.
Findings: Induced pluripotent stem cells don't increase genetic mutations
Despite immense promise, adoption of induced pluripotent stem cells (iPSCs) in biomedical research and medicine has been slowed by concerns that these cells are prone to increased numbers of genetic mutations.
Scientists take aging cardiac stem cells out of semiretirement to improve stem cell therapy
With age, the chromosomes of our cardiac stem cells compress as they move into a state of safe, semiretirement.
Purest yet liver-like cells generated from induced pluripotent stem cells
A team of researchers from the Medical University of South Carolina and elsewhere has found a better way to purify liver cells made from induced pluripotent stem cells.
Stem cell scientists discover genetic switch to increase supply of stem cells from cord blood
International stem cell scientists, co-led in Canada by Dr. John Dick and in the Netherlands by Dr.
Modeling NAFLD with human pluripotent stem cell derived immature hepatocyte like cells
Researchers from the Institute for Stem Cell Research and Regenerative Medicine at the University Clinic of Düsseldorf have established an in vitro model system for investigating nonalcoholic fatty liver disease (NAFLD).
Non-healing tissue from diabetic foot ulcers reprogrammed as pluripotent stem cells
Researchers at Tufts University School of Dental Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts, led by Jonathan Garlick, have established for the first time that skin cells from diabetic foot ulcers can be reprogrammed to acquire properties of embryonic-like cells.
Study sets standards for evaluating pluripotent stem cell quality
As the promise of using regenerative stem cell therapies draws closer, a consortium of biomedical scientists reports about 30 percent of induced pluripotent stem cells they analyzed from 10 research institutions were genetically unstable and not safe for clinical use.

Related Pluripotent Stem Cells Reading:

Frontiers in Pluripotent Stem Cells Research and Therapeutic Potentials Bench-To-Bedside
by Kuldip S. Sidhu (Author)

Atlas of Human Pluripotent Stem Cells in Culture
by Lyn Healy (Author), Ludmila Ruban (Author)

Engineering and Application of Pluripotent Stem Cells (Advances in Biochemical Engineering/Biotechnology)
by Ulrich Martin (Editor), Robert Zweigerdt (Editor), Ina Gruh (Editor)

Human Stem Cell Manual: A Laboratory Guide
by Suzanne Peterson (Editor), Jeanne F. Loring (Editor)

The Science of Stem Cells
by Jonathan M. W. Slack (Author)

Human Pluripotent Stem Cells: Methods and Protocols (Methods in Molecular Biology)
by Philip H. Schwartz (Editor), Robin L. Wesselschmidt (Editor)

Patient-Specific Induced Pluripotent Stem Cell Models: Generation and Characterization (Methods in Molecular Biology)
by Andras Nagy (Editor), Kursad Turksen (Editor)

Induced pluripotent stem cells: Production and utility in regenerative medicine and other applications (Euroscicon Meeting Report)
by Honnao

Induced Pluripotent Stem (iPS) Cells: Methods and Protocols (Methods in Molecular Biology)
by Kursad Turksen (Editor), Andras Nagy (Editor)

Muse Cells: Endogenous Reparative Pluripotent Stem Cells (Advances in Experimental Medicine and Biology Book 1103)
by Springer

Best Science Podcasts 2018

We have hand picked the best science podcasts for 2018. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Circular
We're told if the economy is growing, and if we keep producing, that's a good thing. But at what cost? This hour, TED speakers explore circular systems that regenerate and re-use what we already have. Guests include economist Kate Raworth, environmental activist Tristram Stuart, landscape architect Kate Orff, entrepreneur David Katz, and graphic designer Jessi Arrington.
Now Playing: Science for the People

#503 Postpartum Blues (Rebroadcast)
When a woman gives birth, it seems like everyone wants to know how the baby is doing. What does it weigh? Is it breathing right? Did it cry? But it turns out that, in the United States, we're not doing to great at asking how the mom, who just pushed something the size of a pot roast out of something the size of a Cheerio, is doing. This week we talk to anthropologist Kate Clancy about her postpartum experience and how it is becoming distressingly common, and we speak with Julie Wiebe about prolapse, what it is and how it's...